A. Piguet

U. Dafni, D. de Ruysscher, R. Stahel, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

PI(3)K/PTEN/AKT pathway.

J. Dufour, A. Piguet, 2011, Journal of hepatology.

Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities.

J. Dufour, Syamantak Majumder, S. Chatterjee, 2014, Clinical science.

Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition

J. Dufour, T. Tordjmann, A. Piguet, 2005, Hepatology.

Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma.

J. Dufour, D. Semela, M. V. St-Pierre, 2008, Journal of hepatology.

Targeting vessels to treat hepatocellular carcinoma.

J. Dufour, A. Piguet, P. Romanque, 2008, Clinical science.

Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer

J. Dufour, D. Aebersold, Y. Zimmer, 2015, Genes & cancer.

Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2

J. Dufour, M. Ledermann, E. Waelti, 2007, Journal of drug targeting.

PTEN Down‐Regulation Promotes β‐Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in Mice

M. Foti, J. Dufour, E. Kachaylo, 2017, Hepatology.

Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

J. Dufour, H. Reeves, A. Burt, 2014, Journal of hepatology.

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

K. Clément, G. Alexander, M. Allison, 2014, Nature Communications.

TM6SF2 rs58542926 influences hepatic fibrosis

K. Clément, G. Alexander, M. Allison, 2015 .

TM 6 SF 2 rs 58542926 Influences Hepatic Fibrosis Progression in Patients with Non-Alcoholic Fatty Liver Disease

K. Clément, G. Alexander, M. Allison, 2014 .

Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-RT regimen in unresectable locally advanced NSCLC: The ETOP NICOLAS phase II trial.

U. Dafni, D. Ruysscher, R. Stahel, 2018 .

Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma.

S. Thorgeirsson, C. Brenner, Ju-Seog Lee, 2006, Gastroenterology.

Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis.

J. Dufour, C. Simillion, L. Terracciano, 2015, Journal of hepatology.

Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma.

J. Dufour, D. Semela, R. Hlushchuk, 2007, Journal of hepatology.

P523 SAFETY AND EFFICACY OF AN AUTOMATED LOW FLOW ASCITES (ALFA) PUMP IN CIRRHOTIC PATIENTS WITH REFRACTORY ASCITES

F. Lammert, T. Berg, J. Dufour, 2014 .

Efficacy evaluation of concurrent nivolumab addition to a first-line, concurrent chemo-radiotherapy regimen in unresectable locally advanced NSCLC: Results from the European Thoracic Oncology Platform (ETOP 6-14) NICOLAS phase II trial

U. Dafni, D. Ruysscher, R. Stahel, 2019, Annals of Oncology.